نتایج جستجو برای: bcl11a

تعداد نتایج: 301  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه اصفهان - دانشکده علوم پایه 1392

بتا تالاسمی اینترمدیا یک بیماری اتوزوم مغلوب است که از نظر بالینی طیفی بسیار گسترده و به لحاظ ژنوتیپی نیز گروه بسیار نامتجانسی از اختلال های وابسته به هموگلوبین را شامل می شود و از نظر شدت بیماری، بین تالاسمی ماژور و مینور قرار می گیرد. سطح بالای هموگلوبین جنینی تاثیر عمده ای بر وخامت بیماری دارد، به طوری که افزایش تولید hbf شدت بیماری را کاهش می دهد. عوامل مختلفی هم درون لوکوس بتا گلوبین و هم ...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2014

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2011

Journal: :Annals of hematology & oncology 2022

Genetic studies identify common variants within the HBS1L-MYB intergenic region (HMIP), BCL11A, and Xmn1-HBG2 as associated with elevated fetal hemoglobin (HbF) levels other clinically important human hematological traits. Recent suggest HbF is a predictor of outcome in MDS/AML patients receiving decitabine. We assessed effects genetic on traits Myeloproliferative Neoplasm (MPN), Myelodysplasti...

2017
Xingguo Zhu Tianxiang Hu Meng Hsuan Ho Yongchao Wang Miao Yu Niren Patel Wenhu Pi Jeong-Hyeon Choi Hongyan Xu Vadivel Ganapathy Ferdane Kutlar Abdullah Kutlar Dorothy Tuan

Hydroxyurea (HU), the first of two drugs approved by the US Food and Drug Administration for treating patients with sickle cell disease (SCD), produces anti-sickling effect by re-activating fetal γ-globin gene to enhance production of fetal hemoglobin. However, approximately 30% of the patients do not respond to HU therapy. The molecular basis of non-responsiveness to HU is not clearly understo...

Journal: :Nature Reviews Clinical Oncology 2015

2017
Mohammad Reza MAHDAVI Farzin POURFARZAD Mehrnoush KOSARYAN Mohammad Taghi AKBARI

BACKGROUND The hematologic response to hydroxyurea (HU) is varied among β-thalassemia (BT) patients. The BCL11A and SOX6 genes are involved in response to HU. This study aimed to investigate the in-vitro responsiveness of HU among BT major patients homozygote for IVSII-1G>A mutation and XmnI single nucleotide polymorphism (SNP) in order to find whether the in-vitro Hb concentration is a predict...

2014
Ambroise Wonkam Valentina J. Ngo Bitoungui Anna A. Vorster Raj Ramesar Richard S. Cooper Bamidele Tayo Guillaume Lettre Jeanne Ngogang

BACKGROUND Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical course of sickle cell disease (SCD). Data on this important aspect of SCD have not yet been reported from West Africa. We investigated the relationship between HbF levels and the relevant genetic loci in 610 patients with SCD (98% HbSS homozygotes) from Cameroon, and compared the results ...

Journal: :Proceedings of the National Academy of Sciences 2014

2010
Annemarie M. Simonis-Bik Giel Nijpels Timon W. van Haeften Jeanine J. Houwing-Duistermaat Dorret I. Boomsma Erwin Reiling Els C. van Hove Michaela Diamant Mark H.H. Kramer Robert J. Heine J. Antonie Maassen P. Eline Slagboom Gonneke Willemsen Jacqueline M. Dekker Elisabeth M. Eekhoff Eco J. de Geus Leen M. 't Hart

OBJECTIVE Recently, results from a meta-analysis of genome-wide association studies have yielded a number of novel type 2 diabetes loci. However, conflicting results have been published regarding their effects on insulin secretion and insulin sensitivity. In this study we used hyperglycemic clamps with three different stimuli to test associations between these novel loci and various measures of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید